Could a statin save pregnancies? new trial aims to buy time for At-Risk babies

NCT ID NCT07098975

Recruiting now Disease control Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau Source: ClinicalTrials.gov ↗

First seen Feb 24, 2026 · Last updated May 21, 2026 · Updated 13 times

Summary

This study tests whether a daily dose of pravastatin, a common heart medication, can safely prolong pregnancy in women diagnosed with severe early-onset placental insufficiency. The condition restricts blood flow to the baby, often leading to early delivery. The trial will compare pravastatin to a placebo in 154 pregnant women to see if it delays delivery and reduces complications for both mother and child.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PLACENTAL INSUFFICIENCY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hospital Clínic de Barcelona
NOT_YET_RECRUITING

Barcelona, Spain
Hospital de la Santa Creu i de Sant Pau
RECRUITING

Barcelona, 08025, Spain

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

INTRAUTERINE GROWTH RESTRICTION (IUGR) PLACENTAL INSUFFICIENCY PREECLAMPSIA (PE) PREECLAMPSIA (PE)